Ustekinumab for the treatment of refractory giant cell arteritis

Ann Rheum Dis. 2016 Aug;75(8):1578-9. doi: 10.1136/annrheumdis-2016-209351. Epub 2016 May 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Giant Cell Arteritis / diagnosis
  • Giant Cell Arteritis / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Registries*
  • Severity of Illness Index
  • Treatment Outcome
  • United Kingdom
  • Ustekinumab / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Ustekinumab